Towards the clinical translation of a novel autophagy inhibitor: Bisaminoquinoline derivative nanoparticles.

Saved in:
Bibliographic Details
Title: Towards the clinical translation of a novel autophagy inhibitor: Bisaminoquinoline derivative nanoparticles.
Authors: Mahri S; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA., Tang M; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA., Zong Q; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA., Kim EJ; Department of Internal Medicine, Division of Hematology Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA., Lin TY; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA., Li Y; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA. Electronic address: lypli@health.ucdavis.edu.
Source: Biomaterials [Biomaterials] 2026 Jun 02; Vol. 335, pp. 124361. Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5905 (Electronic) Linking ISSN: 01429612 NLM ISO Abbreviation: Biomaterials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5905
DOI:10.1016/j.biomaterials.2026.124361